background: Mechanisms underlying early reproductive loss in the human are beginning to be elucidated. The migratory and invasive capacity of human endometrial stromal cells (ESCs) is increasingly recognized to contribute to the intense tissue remodelling associated with embryo implantation, trophoblast invasion and endometrial regeneration. In this review, we examine the signals and mechanisms that control ESC migration and invasion and assess how deregulation of these cell functions contributes to common reproductive disorders. Human Reproduction Update, Vol.19, No.5 pp. 542-557, 2013 Advanced Access publication on July 4, 2013 doi:10.1093/humupd/dmt025 conclusions: Novel concepts are extending our understanding of the key functions of ESCs in effecting tissue repair imposed by cyclic menstruation and parturition. Migration of decidualizing ESCs also serves to support blastocyst implantation and embryo selection through discriminate motile responses directed by embryo quality. Targeting regulatory molecules holds promise for developing new strategies for the treatment of reproductive disorders such as endometriosis and recurrent miscarriage; and harnessing the migratory capacity of progenitor mesenchymal stem cells in the endometrium may offer new opportunities in regenerative medicine.
Introduction
Human reproduction is characterized by a high incidence of periimplantation loss (Macklon et al., 2002) . In recent years, research has focused increasingly on the role of endometrium as a determinant of reproductive outcomes. The highly dynamic nature of the human endometrium is well documented. In response to the rise and fall in ovarian hormones, it proliferates, differentiates, sheds and regenerates 400 times during reproductive years. This process of continuous reshaping and regeneration of the endometrium depends on the presence of adult stem cells, migratory resident cells, coordinated influx of specialized immune cells, controlled inflammation and angiogenesis (Gellersen et al., 2007b; Gargett and Ye, 2012) .
The preparatory process for pregnancy starts with the postovulatory surge in circulating progesterone levels. This inhibits oestrogendependent proliferation of the uterine epithelium and induces secretory transformation of the uterine glands. Subsequently, the luminal epithelium expresses an evolutionarily conserved repertoire of molecules essential for stable interaction and adherence of a blastocyst, thus enabling implantation (Lessey, 2000) . Importantly, receptivity is a transient endometrial state, confined to only a few days in the mid-secretory phase of the cycle, and depends on paracrine signals from decidualizing endometrial stromal cells (ESCs) underlying the luminal epithelium (Achache and Revel, 2006) .
Decidualization of the endometrium occurs in those species where pregnancy involves breaching of the luminal endometrial epithelium by the blastocyst (Brosens et al., 2009 ). This process is defined by mesenchymal-to-epithelial transformation of endometrial fibroblasts into secretory decidual cells (Gellersen et al., 2007b) . Decidualization is indispensable for pregnancy as it confers immunotolerance to the fetal semi-allograft, controls trophoblast invasion, and both nourishes and protects the peri-implantation conceptus against a variety of physiological stressors associated with pregnancy (Leitao et al., 2010 (Leitao et al., , 2011 . Decidual ESCs also function as gatekeepers of different immune cells at the implantation site. For example, differentiating ESCs secrete interleukin-11 (IL-11) and IL-15, implicated in recruitment and differentiation of uterine natural killer cells, which in turn are a rich source of angiogenic factors (King, 2000; Dimitriadis et al., 2005; Hanna et al., 2006) . In most species, the implanting embryo triggers the decidual process. In human beings, however, decidualization is under maternal control and initiated during the mid-secretory phase of each cycle in response to elevated progesterone and rising cellular cAMP levels (Gellersen and Brosens, 2003) . ESCs first mount an acute auto-inflammatory response upon decidualization, which in turn triggers the expression of key receptivity genes in the overlying endometrial surface epithelium (Salker et al., 2012) . This pro-inflammatory phenotype is transient, determines the duration of the window of implantation and is followed by an antiinflammatory response essential for post-implantation embryo support and coordinated trophoblast invasion (Salker et al., 2012) .
In the absence of pregnancy, falling progesterone levels reactivate the expression of inflammatory mediators in decidualizing ESCs triggering apoptosis, influx of immune cells, extracellular matrix (ECM) breakdown and menstrual shedding (Lockwood et al., 1997; Critchley et al., 2001; Brosens et al., 2009 ). An inevitable consequence of menstruation is the need for cyclic regeneration and renewal of the endometrium. The regenerative capacity of the human endometrium is indeed remarkable. It is rich in mesenchymal stem-like cells (MSCs) residing predominantly around the vessels (Gargett and Ye, 2012) . They are recruited to the endometrium in response to hypoxic, proteolytic and inflammatory stimuli associated with cyclic menstruation, pregnancy and parturition. In fact, purified ESCs also express elevated levels of pluripotency factors, and are more amenable to induced pluripotent stem cell reprogramming compared with conventional somatic cells (Park et al., 2011; Chen et al., 2012) . Molecular phenotyping indicates that ESCs are closely related to follicular dendritic cells (FDCs) (Muñoz-Fernández et al., 2012) . Intriguingly, ESCs and FDCs both originate from perivascular platelet-derived growth factor receptor b-positive (PDGFRb + ) adult stem/precursor cells, differentiate in response to inflammatory signals (Krautler et al., 2012) and are key to local and systemic maternal immunotolerance in pregnancy, respectively (McCloskey et al., 2011; Nancy et al., 2012) . The malleability of uterine tissues is both tested and exemplified during pregnancy. When it comes to pregnancy, the decidualizing endometrial stroma is widely viewed as an immunoprivileged but passive matrix, seemingly there only to accommodate the highly invasive semi-allogeneic blastocyst and then support deep uterine invasion of extra-embryonic trophoblast (Norwitz et al., 2001; Red-Horse et al., 2004) . However, this view has recently been challenged by studies demonstrating that coordinated migration and invasiveness of decidualizing ESCs in response to embryonic and trophoblast signals are key to successful implantation. In addition, endometrial cells are capable of invading distant sites, leading to pelvic endometriosis or uterine adenomyosis (Bulun, 2009; Burney and Giudice, 2012; Maheshwari et al., 2012) .
Cell migration and invasion are fundamental to many physiological processes, including development, wound healing and immune responses (Friedl and Wolf, 2003; Petrie et al., 2009) . By extension, the migratory and invasive capacity of mature ESCs and progenitor cells is increasingly recognized to underpin the intense tissue remodelling associated with endometrial regeneration, decidualization, embryo implantation and trophoblast invasion. In this review, we examine the signals and mechanisms that control ESCs migration and invasion and assess how deregulation of these cell functions contributes to common reproductive disorders, such as implantation failure and recurrent pregnancy loss (RPL), pelvic endometriosis and adenomyosis.
Endometrial stromal cell migration
Methods
Electronic searches were performed in the PubMed database focusing on motility of ESCs in normal uterine function and in reproductive disorders, using the keywords 'ESCs' in conjunction with 'migration', 'invasion' or 'motility'. The searches were restricted to articles published in the English language and covered the period from 2000 to December 2012. Earlier relevant publications were accessible from previously conducted searches and cross references were picked up during the review process.
Results

Basic mechanisms of migration and invasion
Cellular locomotion in response to a signal can be classified into two major types: chemokinesis and chemotaxis. Chemokinesis occurs when a factor stimulates cell motility without determining the direction of migration; chemotaxis takes place when cells migrate towards a chemoattractant in a concentration gradient (Petrie et al., 2009) . Simplified, chemokinesis is a random and non-directed type of migration, whereas chemotaxis is directed locomotion in response to an external cue. A prototypical stimulus for chemokinesis is the angiogenic platelet-derived growth factor (PDGF)-BB when applied to cells in a homogeneous solution. PDGF-BB, however, can also act as a chemoattractant when applied asymmetrically (Hinton et al., 1998) .
Pivotal players in the regulation of migration are Rho family small guanosine triphosphate (GTP)-binding proteins (GTPases). They control organization of the actin cytoskeleton and the formation of cellular protrusions. More than 20 members of the Rho GTPase family have been identified, including RhoA, Rac1 and CDC42. In their active GTP-bound state, Rho GTPases perform their function through effector proteins, e.g. Rho-associated serine/threonine kinase (ROCK) among many others. Rac1 and CDC42 initiate the formation of a branched actin filament network, whereas RhoA promotes linear elongation of actin filaments (Jaffe and Hall, 2005) .
A four-step model describes two-dimensional cell migration on biological surfaces (Lauffenburger and Horwitz, 1996; Friedl and Wolf, 2003; Mitra et al., 2005) . (i) Protrusion of the leading edge: growing actin filaments, controlled by Rac and CDC42 activity, push the cell membrane outward. (ii) Cell matrix interactions and formation of focal contacts: integrins serve as receptors for ECM proteins, such as collagen, laminin and fibronectin. Focal contacts are dynamic complexes linking ECM, integrins and the cytoskeleton. Focal adhesion kinase (FAK) is recruited to these sites and regulates both their assembly and turnover. (iii) Cell contraction by actomyosin: myosin light chain (MLC) is phosphorylated by MLC kinase and de-phosphorylated by MLC phosphatase. The extent of MLC phosphorylation is regulated by RhoA through its effector ROCK, which phosphorylates and thus inhibits MLCP, resulting in actomyosin contraction. (iv) Detachment of the rear end: focal contacts disassemble and integrins detach from the substrate.
Invasion denotes cellular movement within tissues and requires degradation of the ECM. Focalized proteolysis by surface proteases generates active soluble matrix metalloproteinases (MMPs) with selected specificities for ECM components. Invasion further involves the action of cysteine-and serine-proteases, such as kallikreins and plasminogen activators (PA), and is counteracted by tissue inhibitors of MMPs (TIMPs) and PA inhibitor secreted by cells of the invaded tissue (Salamonsen, 1999).
Experimentally, chemokinesis can be assessed in vitro by quantifying horizontal migration in a uniform solution using a wound healing (or 'scratch') assay where cells grown in a monolayer migrate into a cell-free detection zone (Rodriguez et al., 2005) . Chemotaxis is commonly measured in a modified Boyden chamber setting, using transwell migration inserts where cells are plated on a porous membrane and move vertically through the pores towards a chemoattractant in the lower compartment (Gerthoffer, 2007) . When the porous membrane is coated with ECM, such as Matrigel, transwell migration of the cells reflects their invasiveness.
ESC migration and endometriosis
Our search retrieved 53 original research articles investigating ESC motility and invasiveness. Among these, two papers dealt with adenomyosis and one with RPL while studies on endometriosis represented the majority (32 publications).
Invasiveness of ectopic versus eutopic ESCs
Perhaps not surprisingly, the first demonstration of the invasiveness of ESCs came from studies aimed at elucidating the cellular basis of endometriotic implants. In an attempt to isolate the invasive cell type(s) in endometriotic lesions, Zeitvogel et al. (2001) (Zeitvogel et al., 2001) , and their migratory and invasive characteristics have since been substantiated in other studies (Banu et al., 2008; Lee et al., 2011 ). Sampson's retrograde implantation theory (Sampson, 1927) assumes that the invading endometriotic cells originate from the eutopic endometrium shed at menstruation. To visualize this process, fragments of normal endometrium were co-cultured with peritoneal explants (Witz et al., 2002) . The intact layer of mesothelium was breached by ESCs within 24 h of co-culture, thus representing the first step in the invasion process. When plated on dispersed peritoneal mesothelial cells (PMCs), ESCs rapidly extended pseudopodia under the mesothelial cell layer (Witz et al., 2003) . Similarly, ESCs were found to invade PMCs plated in Matrigel-coated chambers. This was enhanced by activin A and associated with increased production of the gelatinases MMP-2 and MMP-9 (Ferreira et al., 2008) . Further, it was shown that the presence of PMCs greatly enhances the invasion of ESCs through Matrigel-coated membranes, and that co-cultured PMCs induce the expression of several genes in the ESCs, including those coding for colony stimulating factor-1 (CSF-1), its receptor c-fms and the hepatocyte growth factor (HGF) receptor c-MET (Nair et al., 2008) . HGF concentrations, in turn, are elevated in the peritoneal fluid of women with endometriosis compared with women without endometriosis, and HGF stimulates the invasiveness of endometriotic cells to a higher extent than that of normal ESCs (Yoshida et al., 2004) (Table I) .
The invasiveness of ectopic ESCs was reported to be more pronounced than that of their eutopic counterparts in patients with 
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Endometrial stromal cell migration endometriosis, which in turn is greater than the invasiveness of ESCs from disease-free subjects (Ornek et al., 2008) . These differences in invasiveness were shown to correlate with increased expression of ezrin, a member of the ezrin/radixin/moesin family of proteins that act as linkers between actin filaments and plasma membrane proteins (Ornek et al., 2008; Arpin et al., 2011) . Silencing of ezrin impaired wound healing motility of ESCs (Jiang et al., 2012) . However, Yotova et al. (2012) arrived at a different ranking when assessing the migratory capacity of normal and endometriotic ESCs. In their hands, ectopic ESCs were the least motile, which was attributed to the cells retaining a contracted phenotype. In contrast, the morphology of eutopic ESCs appeared more dynamic. MSCs have been isolated from paired eutopic and ectopic endometrial samples and compared for their invasive potential (Kao et al., 2011a) . Ectopic MSCs were markedly more invasive than their eutopic counterparts. Gene expression profiling revealed pronounced up-regulation of numerous transcripts in ectopic compared with eutopic endometrial MSCs, including several encoding chemokines, cytokines like IL-1b and cyclo-oxygenase 2 (COX-2), the rate-limiting enzyme in prostaglandin E2 (PGE2) synthesis (Kao et al., 2011b) . Of note, movement of cells between the eutopic and ectopic endometrium may be bidirectional. Migration of ectopic endometrial cells to the eutopic endometrium has been documented in an endometriosis mouse model (Santamaria et al., 2012) . The migrated cells relocated primarily to the stroma in the basal layer of the endometrium and their expression profile revealed characteristics of cells having undergone epithelial-to-mesenchymal transition. Aberrant activation of the Wnt-signalling pathway in the homed cells was suggested to disturb endometrial receptivity and contribute to infertility often linked with endometriosis (Bulun, 2009; Santamaria et al., 2012) .
Impact of the pelvic microenvironment on ESC migration and invasion
Endometriosis is a chronic pelvic inflammatory condition characterized by increased numbers of activated macrophages and a distinct cytokine/chemokine profile in the peritoneal fluid (Burney and Giudice, 2012) . Chemokines are small chemoattractant cytokines that were originally characterized for their role in leukocyte trafficking (Blanchet et al., 2012) . In fact, they are involved in many physiological and pathological processes, including tumorigenesis and metastasis. Chemokine receptors belong to the family of G-protein coupled receptors (GPCR) (Blanchet et al., 2012) . As key inflammatory regulators, the role of chemokines in endometriosis is receiving increased attention and several, including C-C motif ligand (CCL)2, CCL3 (MIP-1a) and CCL5 (RANTES), have been shown to stimulate ESC invasiveness (Yu et al., 2008; Li et al., 2012) . Furthermore, the pro-inflammatory cytokine IL-1b promotes chemotaxis and invasiveness of endometriotic ESCs (Zhang et al., 2011) and of MSCs isolated from ovarian endometriomas (Kao et al., 2011b ) (see Table I ). Induction of an inflammatory response by WH, wound healing (horizontal chemokinesis in wound healing or ORIS TM migration assay); CT, chemotaxis (vertical transwell migration in chemotactic gradient); INV, invasion (transwell migration through ECM/Matrigel-coated membrane); IMPL, facilitation of human or mouse blastocyst implantation co-cultured on ESCs monolayer. COX, cyclooxygenase; EGF, epidermal growth factor; HDAC, histone deacetylase; FGF, fibroblast growth factor; HG-EGF, heparin binding-epidermal growth factor HGF, hepatocyte growth factor IDO1, Indoleamine 2,3-dioxygenase-1 IL, interleukin LPS, lipopolysaccharide MIP, macrophage inflammatory protein PDGF, platelet derived growth factor PGE, prostaglandin E RANTES, regulated on activation normal T cell expressed and secreted TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; TGF, transforming growth factor; TSA, Trichostatin A. lipopolysaccharide (LPS), a structural component of the outer wall of gram-negative bacteria, also enhances the invasiveness of ESCs from women with endometriosis (Takenaka et al., 2010; Mei et al., 2012) . The concentration of thymus-expressed chemokine, TECK (CCL25), is reportedly increased in the peritoneal fluid of women with endometriosis. Further, the expression of the corresponding receptor CCR9 is also higher in endometriotic than in normal ESCs (Wang et al., 2010) . Invasiveness of eutopic endometriotic ESCs, co-cultured with PMCs and a human monocyte cell line, can be stimulated by the combination of estradiol with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). This has been attributed to enhanced TECK secretion by the co-cultured cells and TECK-dependent MMP-2/MMP-9 production (Wang et al., 2010) .
Elevated COX-2 expression in endometriotic ESCs results in augmented PGE2 production (Banu et al., 2008) . Pharmacological inhibition or silencing of COX-2 restricts invasiveness of the 22B endometriotic stromal cell line partly by reducing MMP-2 and MMP-9 activities (Banu et al., 2008) . These observations suggest an important paracrine role of PGE2 in regulating ESC invasive activity at ectopic sites. In support of this, selective inhibition or silencing of the PGE2 receptors EP2 and EP4 was shown to blunt migration and invasion of 22B cells along with a reciprocal reduction and enhancement in MMP-2/MMP-9 and TIMP expression, respectively . Similarly, IL-1b-induced migration and invasiveness of MSCs from ovarian endometriomas involves up-regulation of COX-2 (Kao et al., 2011b) . Interestingly, enhanced MMP expression, migration and invasion of ectopic ESCs in response to IL-1b can be antagonized with pyrrolidine dithiocarbamate, an antioxidant and potent inhibitor of nuclear factor (NF)-kB (Zhang et al., 2011) . The expression of indoleamine 2,3-dioxygenase-1 (IDO1), a ratelimiting enzyme in the catabolism of the essential amino acid tryptophan, is reportedly also increased in ectopic versus normal ESCs. IDO1 is induced in response to LPS and, conversely, pharmacological inhibition of IDO1 reduces LPS-dependent ESC invasion . Interestingly, the ability of LPS to induce PGE2 production and to stimulate ESC invasiveness in a COX-2 dependent manner was reported to be confined to ectopic but not eutopic cells (Takenaka et al., 2010) .
In addition to COX-2, several steroidogenic enzymes, foremost aromatase and estrone sulfatase, are highly expressed in endometriotic tissue, resulting in a local prostaglandin-and oestrogen-rich environment (Bulun, 2009; Wu et al., 2010; Burney and Giudice, 2012) . Both factors engage in a positive feed-forward loop leading to-among other end-points-enhanced invasive activity of ectopic ESCs (Fig. 1) . Interestingly, ESCs from patients with endometriosis display a different migratory response to ovarian steroid hormones than ESCs from normal controls (Gentilini et al., 2010b) . While progesterone reduced chemotactic migration of normal ESCs, it had a stimulatory effect on ESCs derived from patients with endometriosis. Moreover, 17b-estradiol induced a pro-migratory phenotype that was more pronounced in the endometriotic group compared with the controls.
Recently, the role of microRNAs in the pathogenesis of endometriosis has received considerable attention. The microRNA miR-199a attenuates the invasive capability of ESCs partly by suppressing NF-kB signalling and IL-8 production (Dai et al., 2012) . MiR-199a was found to be down-regulated in endometriosis (Dai et al., 2012) ; and the resultant increase in IL-8 levels may stimulate ESC invasiveness (Mulayim et al., 2004) .
Targeting ESC migration/invasion in endometriosis
Numerous strategies have been explored to target invasiveness of endometrial cells for the treatment of endometriosis. Cannabinoid receptors CB1 and CB2 are GPCRs that couple to the phosphatidylinositol-3-kinase (PI3K)/AKT and ERK1/2 mitogen-activated protein kinase pathways. They are expressed in normal endometrium as well as endometriotic tissues (Sanchez et al., 2012) . While CB1/CB2 agonists rather tend to exert an anti-proliferative effect on endometriotic ESCs (Sanchez et al., 2012) , the CB1 agonist methanandamide was shown to enhance migration of ESCs (Gentilini et al., 2010a) . Thus, the usefulness of targeting the endocannabinoid system in the treatment of endometriosis requires further clarification (Sanchez et al., 2012) .
PDGF-BB stimulates chemokinetic motility of ectopic ESCs from endometriosis. This is antagonized by somatostatin and its natural analogue cortistatin (Annunziata et al., 2012) . Somatostatin, cortistatin and all seven members of the somatostatin receptor family are expressed in endometriotic tissues (Annunziata et al., 2012) . Another study reported increased expression of somatostatin receptors SST1, SST2 and SST5 in ovarian endometriomas and found that the SST ligand octreotide had anti-migratory properties (Fasciani et al., 2010) .
Statins, a class of drugs that inhibit HMG-CoA (3-hydroxy-3-methylglutaryl-co-enzyme A reductase), are widely used for the treatment of hypercholesterolaemia. Statins are anti-angiogenic, which Figure 1 Central role of COX-2 in ectopic ESC invasion.
Pro-inflammatory cytokines including interleukin (IL)-1b activate COX-2, leading to increased PGE2 production. Autocrine/paracrine PGE2 activates EP2/EP4 receptors, resulting in stimulation of COX-2, aromatase and MMP-2/MMP-9 expression. Increased estradiol (E 2 ) stimulates COX-2 and supports motility in endometriotic ESCs. Elevated MMP activity promotes ECM degradation and supports invasion into the peritoneum (green arrows: activation, blue arrows: production).
Endometrial stromal cell migration renders them promising compounds for the treatment of endometriosis (Laschke and Menger, 2012) . Simvastatin has been shown to prevent endometriosis in a nude mouse model (Bruner-Tran et al., 2009) . In addition to inhibiting vascularization in the endometriotic lesions in vivo (Bruner-Tran et al., 2009), statins cause a shift in the relative expression of MMP-2/MMP-3 to TIMP-2 in favour of the MMP inhibitor, which in turn could account for reduced invasiveness of cultured ESCs in response to the drug (Sokalska et al., 2012) .
The natural phenol resveratrol, found in the skin of red grapes and other fruits, has broad anti-proliferative and anti-invasive actions in a variety of cells, although its precise mechanisms of action remain largely unresolved (Athar et al., 2009; Gupta et al., 2010) . It can also inhibit the development of endometriosis in a nude mouse model and the invasiveness of normal ESCs in vitro (Bruner-Tran et al., 2011) .
ESC migration and adenomyosis
The putative role of ESC invasiveness in the aetiology of adenomyosis, a prevalent condition characterized histologically by the presence of ectopic endometrial tissue in the myometrium, has also been investigated. Notably, the diagnosis of adenomyosis by imaging modalities, such as ultrasound and magnetic resonance, is primarily based on visualizing the smooth muscle changes in the uterine junctional zone. In adenomyosis, myocytes exhibit cellular hypertrophy and show differences in cytoplasmic organelles, nuclear structures and intercellular junctions Benagiano et al., 2012) . A recent study reported that ESC invasion into a thick layer of plain collagen was more pronounced when cells were obtained from adenomyotic compared with control uteri. In a complementary experiment, myocytes from control subjects and from patients with adenomyosis were embedded in the collagen. Interestingly, myocytes from adenomyosis enhanced the invasion of ESCs when compared with normal myocytes, implying that adenomyosis is a disease of both the endometrial stroma and the myometrium (Mehasseb et al., 2010) . Another study, however, found no difference in the invasiveness of eutopic ESCs from women with or without adenomyosis (Yang et al., 2009) .
ESC migration and endometrial regeneration
Although studies on endometriosis represented a majority of publications identified in our search, they often involved ESCs from disease-free subjects. Consequently, it is beyond doubt that normal ESCs are inherently motile as well as invasive. Further, an astonishing array of regulatory signals and mechanisms has emerged that control these cellular functions in ESCs. Stimulatory factors include the chemokines CCL2, CXCL12 and IL-8 (CXCL8), growth factors such as epidermal growth factor (EGF), fibroblast growth factor-2 (FGF-2), heparin-binding EGF-like growth factor (HB-EGF), HGF and the PDGF dimeric isoforms -AA, -AB and -BB, as well as activin A and 17b-estradiol (Table I and references therein). Among the inhibitory signals are transforming growth factor b (TGFb), progesterone and somatostatin receptor ligands (Table I and  references therein) . Interestingly, a number of these factors, including oestrogen, activins, FGFs and TGFb, are increasingly implicated in endometrial repair following menstruation (Salamonsen, 2003) . Furthermore, the angiogenic growth factor PDGF-BB, very likely a key regulator of menstrual vascular repair, has evolved as a potent stimulator of random motility, chemotactic migration and invasion of ESCs Schwenke et al., 2013) . In the proliferative phase of the menstrual cycle, PDGF-BB is produced primarily in endometrial endothelial cells, while ESCs express PDGF receptors (Lash et al., 2012) . A contributory function of PDGF-BB in menstrual tissue repair may therefore be to enhance the pro-migratory effect of estrogen on ESCs (Gentilini et al., 2007 (Gentilini et al., , 2010b Flamini et al., 2011) . Notably, endometrial regeneration also follows parturition and endometrial resection but the underlying mechanisms remain poorly understood. Genetic fate mapping in mice strongly indicated that post-partum re-epithelization of the endometrium is effected by trans-differentiation of progenitor cells within the endometrial stromal compartment (Huang et al., 2012) .
Interestingly, numerous epidemiological studies have indicated that nulliparous women and women reporting short and heavy menstrual cycles are at increased risk of developing endometriosis (Vigano et al., 2004) . Hence, it is conceivable that an increased need for menstrual regeneration may directly account for the intrinsic ability of ESCs to trigger tissue remodelling at distant sites in patients with endometriosis.
ESC migration and embryo implantation
A hitherto largely neglected function of ESC migration involves the implantation process. Once a blastocyst breaches the luminal epithelium, the quality of interactions between the invading embryo and surrounding decidual cells will determine pregnancy failure or success. To assess this very early stage of human pregnancy, Grewal et al. (2008 Grewal et al. ( , 2010 utilized an in vitro implantation model of human or mouse blastocysts placed on a monolayer of decidualizing ESCs. Intriguingly, motility of the ESCs surrounding the blastocyst appears to be essential for successful implantation. In time-lapse imaging studies covering a period of 48 h, highly migratory ESCs were noticeable at the periphery of the embryo. Inhibition of ESC motility suppressed trophoblast invasion into the ESC monolayer (Grewal et al., 2008 (Grewal et al., , 2010 . In another implantation model, which used trophoblast spheroids instead of blastocysts, decidualizing ESCs were shown to align around the expanding spheroid, rendering them a more supportive matrix for trophoblast expansion than non-decidualized ESCs (Gonzalez et al., 2011) .
Migration is one of many cellular functions altered upon decidualization of ESCs . In transwell migration and invasion assays, ESC motility was enhanced in decidualizing compared with undifferentiated ESCs. One underlying mechanism involves the up-regulation of MMP-2/MMP-9 activity upon decidualization . ESC invasion and chemotactic migration are further enhanced when decidualizing cells are in contact with extravillous trophoblast cells or exposed to conditioned medium from trophoblast or first trimester villous explant cultures Schwenke et al., 2013) (Table I ). Proteome analysis of trophoblast and villous explant secretions identified PDGF-AA as a putative embryonic/fetal signal that mobilizes ESCs at the implantation site . A transcriptome analysis, undertaken to unravel communication networks between human trophectoderm and endometrial cells at the time of implantation, found PDGF-AA expressed in trophectoderm from Day 5 implantationcompetent blastocysts while the corresponding receptor was expressed in the receptive endometrium (Haouzi et al., 2011) . CXCL12 (also known as stromal-derived factor-1a, SDF-1a) may be another important factor to stimulate ESC migration. Trophoblast cell-derived CXCL12 was shown to up-regulate CXCR4 (the receptor for CXCL12) in decidual stromal cells isolated from first trimester pregnancies and to promote their invasiveness (Ren et al., 2012) . HB-EGF is as an important multi-functional mediator of embryouterine communication during implantation (Jessmon et al., 2009; Lim and Dey, 2009) . Recently, HB-EGF has been described as a chemoattractant for ESCs . Again, the responsiveness of ESCs to HB-EGF increased upon decidualization concomitantly with enhanced expression of the receptor EGFR . In the pregnant mouse uterus, HB-EGF is most highly expressed in the luminal epithelium in proximity of the implanting blastocyst (Lim and Dey, 2009) , raising the possibility that this epithelial response mobilizes decidualizing ESCs at the site of implantation. PDGF-BB is a stimulus of chemokinesis and chemotaxis not only in undifferentiated but also in decidualizing ESCs and may further support intense tissue remodelling at the implantation site .
CD82 is a metastasis suppressor belonging to the tetraspanins, a family of glycoprotein plasma membrane molecules with four membranespanning domains. The metastasis suppressor function of CD82 relies on multiple mechanisms, including the inhibition of cellular motility and invasiveness in tumour cells (Tsai and Weissman, 2011) . In early pregnancy tissue, CD82 is expressed in decidual cells at the fetal-maternal interface, hinting at a role in the control of trophoblast invasion (Gellersen et al., 2007a) . Li et al. (2011) reported that CD82 silencing increased the invasiveness of normal, eutopic and ectopic ESCs, in line with the common view of CD82 as a metastasis suppressor. Our own recent studies, however, pointed towards the opposite role of CD82 in controlling ESC motility. CD82 protein is low or undetectable in proliferative ESCs but up-regulated upon decidualization. Furthermore, the pro-inflammatory cytokine IL-1b massively induced CD82 expression in ESCs and supported the outgrowth of trophoblast spheroids on CD82-positive ESCs in an implantation model (Gellersen et al., 2007a; Gonzalez et al., 2011) . Decidualized, CD82-positive ESCs are highly responsive to trophoblast signals in migration and invasion assays . Most importantly, silencing of CD82 in decidualizing ESCs in our hands resulted in a drastic attenuation of chemotactic migration . Taken together, our data provide strong evidence for a pro-migratory role of CD82 in ESCs, especially in the context of implantation and placenta formation.
Dynamic changes in histone acetylation, effected by histone acetyltransferases and histone deacetylases (HDAC), constitute an important epigenetic mechanism in the regulation of gene expression (Roth et al., 2001) . Treatment of ESCs with the HDAC inhibitor trichostatin A (TSA) has been shown to enhance ovarian steroid hormoneinduced secretion of the decidual marker proteins prolactin and insulin-like growth factor-binding protein 1 (Sakai et al., 2003) . TSA treatment has recently been reported to inhibit wound healing motility and invasiveness of ESCs, and to limit the invasion of co-cultured mouse embryos. This was attributed to decreased MMP-2/-9 but increased TIMP-1/-3 expression in the ESCs as a consequence of HDAC inhibition (Estella et al., 2012) .
In summary, the paradigm of implantation as being a process solely dependent on the invasion of trophoblast into a static decidual matrix is no longer tenable. ESCs are highly responsive to trophoblast signals and this is further enhanced upon decidualization (Grewal et al., 2008; Brosens and Gellersen, 2010) . Differentiating ESCs have the capacity to actively promote implantation by moving around and encapsulating the conceptus. In co-culture, decidual cells secrete higher levels of MMPs than cytotrophoblast, and again invasive potential is further increased by the presence of the cytotrophoblast cells (Cohen et al., 2010) . Thus, active remodelling of the ECM and migration of decidual cells are likely to be critical well beyond the initial stages of the implantation process by regulating deep trophoblast invasion and the formation of a haemochorial placenta.
ESC migration and early pregnancy loss
During preimplantation development, human embryos exhibit intrinsic chromosomal instability, which frequently results in whole chromosome aneuploidies and segmental imbalances (Voullaire et al., 2000; Wells and Delhanty, 2000; Bielanska et al., 2002; Delhanty, 2005; Baart et al., 2006; Vanneste et al., 2009) , and hence high rates of early pregnancy loss (Macklon et al., 2002) . Consequently, it has been argued that reproductive success is dependent not only on a receptive but also a selective endometrium. This notion of maternal 'selectivity' is underpinned by the observation that-upon decidualization-ESCs become biosensors that respond selectively to developmentally abnormal embryos (Teklenburg et al., 2010b) . Other studies have shown that the responsiveness of primary ESCs to decidualizing cues is disordered in patients suffering from RPL and characterized by prolonged expression of pro-implantation genes (Salker et al., 2012) , lack of embryo recognition (Salker et al., 2010; Weimar et al., 2012) and increased sensitivity to oxidative stress (Salker et al., 2011) . Thus, the functional hallmark of the endometrium in RPL is a prolonged window of implantation ('super-receptive' endometrium), which facilitates out-of-phase implantation of poor quality embryos and compromises post-implantation development of high-quality embryos (Teklenburg et al., 2010a; Salker et al., 2012) .
Cell migration analysis of primary co-cultures has yielded strong evidence in support of the 'super-receptive' phenotype associated with RPL (Weimar et al., 2012) . Migration of decidualizing ESCs from normal fertile and RPL women in response to the presence or absence of a high-or low-quality embryo was assessed in a modified woundhealing assay. When low-quality-but not high-quality-embryos were placed in the cell-free zone, the migratory activity of decidualizing ESCs from fertile women was completely inhibited. In contrast, decidualizing ESCs of women with RPL migrated at comparable rates towards embryos, irrespectively of quality. In addition, chemotaxis towards trophoblast spheroids was more pronounced in primary cultures of ESCs obtained from patients with RPL. Combined, these observations suggest that ESCs from women suffering from RPL exhibit a heightened but indiscriminate migratory response to trophoblast signals (Weimar et al., 2012) . In contrast, decidualizing ESCs from control subjects are programmed not to support implantation of developmentally compromised embryos. Although the underlying molecular mechanisms require further elucidation, other co-culture studies have shown that decidualizing cells respond to the presence of an arresting embryo by selectively inhibiting the secretion of certain cytokines and growth factors (Teklenburg et al., 2010b) . Remarkably, among the down-regulated factors are IL-1b and HB-EGF, which have emerged as prominent regulators of ESC motility (Table I ). The nature of signals emanating from developmentally compromised human embryos is unknown. However, compromised embryos have been shown to be metabolically highly active, producing high levels of ATP and reactive oxygen species, and exhibit increased amino acid turnover when compared with normal embryos ( Continued tempting to speculate that these metabolite profiles convey information on embryo quality to decidualizing ESCs, which in turn are programmed to resist implantation of developmentally impaired embryos.
Signalling pathways in ESC migration
An important functional determinant of migration is contractile activity. Contractility of proliferative ESCs is stimulated by PDGF-BB, along with chemokinesis and chemotaxis . ESCs cultured in collagen lattices showed myofibroblast differentiation and contractile activity which was higher in endometriotic compared with normal ESCs (Yuge et al., 2007) . Decidualizing treatment with cAMP analogue and progestin reduced contractility and down-regulated RhoA, ROCK and a-smooth muscle actin (a-SMA) expression (Tsuno et al., 2009) . It was suggested that attenuation of contractility may be a mechanism by which oral contraceptives, or conception, ameliorate endometriosis (Tsuno et al., 2009) . Down-regulation of a-SMA is a key feature of decidualization, facilitating the cytoskeletal changes associated with differentiation of ESCs (Fazleabas et al., 2004) . Treatment with trophoblast secretions augments the depletion of a-SMA in decidualizing ESCs (Gonzalez et al., 2011) , coinciding with enhanced chemotactic and invasive migration towards trophoblast signals . FAK silencing disrupts focal adhesion turnover in ESC and thereby inhibits ESC motility and implantation of a co-cultured embryo (Grewal et al., 2010) . Remarkably, FAK is up-regulated during ESC decidualization (Ihnatovych et al., 2007) .
Multiple lines of evidence suggest that signalling through the Ras/Raf/ MEK/ERK pathway (Chang et al., 2003) mediates chemotactic and invasive responses of ESCs (Table II) . Raf-1 silencing reduced the migratory activity of ESCs (Yotova et al., 2011 (Yotova et al., , 2012 . Raf-1 inhibition reduced the attachment of ESCs to PMCs and trans-mesothelial invasion, suggesting that Raf-1 signalling mediates invasion into the peritoneum (De La Garza et al., 2012) . MEK inhibitors suppressed the migration in response to endocannabinoids, EGF, FGF-2 and PDGF-BB in normal ESCs (Gentilini et al., 2007 (Gentilini et al., , 2010a , CCL2-stimulated invasion of endometriotic ESCs , and IL-1b-induced chemotaxis and invasiveness of endometriotic MSCs (Kao et al., 2011b) . Furthermore, basal migration of decidualizing ESCs was reduced upon MEK inhibition . All these observations point to a central role of ERK1/2 activation in ESC migration and invasion (Fig. 2) .
The PI3K/AKT pathway (Scheid and Woodgett, 2003) appears equally involved in the control of chemotaxis and invasion (Gentilini et al., 2007 (Gentilini et al., , 2010a Li et al., 2012; Schwenke et al., 2013) (Table II) . Furthermore, PI3K/AKT signalling emerged as the major pathway in the control of chemokinesis (Fig. 2) .
In addition to AKT, the Rho GTPase Rac1 is a downstream effector of PI3K (Schiller, 2006) . Activated Rac1 antagonizes RhoA (Sander et al., 1999) , resulting in ROCK inhibition (Fig. 2) . Pharmacological ROCK inhibition in decidualizing ESCs stimulates chemokinesis and chemotaxis and facilitates the invasion of blastocysts in an in-vitro implantation model (Grewal et al., 2008 (Grewal et al., , 2010 Schwenke et al., 2013) . Implantation is also supported when CDC42 or RhoA, the upstream effector of ROCK, is silenced in the ESC monolayer (Grewal et al., 2008 (Grewal et al., , 2010 . Conversely, the inhibition of the RhoA counter player Rac1 reduces ESC migration and is detrimental to blastocyst implantation (Grewal et al., 2008 (Grewal et al., , 2010 (Table II) . Importantly, Rac1 activity is particularly high in ESCs in immediate contact with invading trophoblast, indicating a localized, pro-migratory effect of the implanting blastocyst on the adjacent ESCs (Grewal et al., 2008) .
Conflicting interpretations regarding the role of ROCK in controlling ESC migration were reported by Yotova et al. (2011 Yotova et al. ( , 2012 . Selective silencing of ROCK-II inhibited chemotaxis in normal, and in eutopic endometriotic ESCs, but enhanced chemotaxis in ectopic ESCs. It remains to be determined if the isoforms ROCK-I and ROCK-II, which are both targeted by pharmacological ROCK inhibitors, contribute differently to ESC motility.
One of the growth factors feeding into the ROCK pathway may be PDGF-BB. endocytosis and Rac1 activation at the cell membrane (Kawada et al., 2009) , contributing to ROCK inhibition and enhanced motility. Decidualization concurs with sustained diminishment of total, and consequently, of phospho-MLC2 , while increased phosphorylation of MLC prevents in vitro decidualization (Ihnatovych et al., 2007) . Importantly, ROCK inhibition in ESCs causes a rapid decrease in MLC2 phosphorylation supportive of decidualization and migratory activity.
Taken together, the following picture on RhoA signalling in ESCs emerges: in non-motile cells, RhoA induces ROCK activity which leads to increased levels of phospho-MLC by dual action as ROCK directly phosphorylates MLC and inhibits MLC phosphatase. Phospho-MLC causes stress fibre formation and focal adhesion and blocks migration in ESCs. Down-regulation of RhoA signalling is pro-migratory and can be brought about by decidualization, in response to growth factor stimulation and in response to trophoblast-derived signals. Growth factors, chemokines, cytokines and trophoblast products further activate ERK1/2 and PI3K/AKT signalling to enhance ESC migratory and invasive capacities in support of implantation (Fig. 2) .
Clinical perspectives and emerging concepts
While pelvic endometriosis provided a clinical rationale to explore ESC motility and invasiveness, it is increasingly apparent that these cellular functions are fundamental to all key reproductive events, including decidualization, implantation, placental formation and endometrial regeneration after menstruation, parturition, miscarriage or surgical intervention (Fig. 3) . It is also apparent that the migratory function of ESCs is tightly controlled and differs between undifferentiated and decidualized cells. Specifically, local gradients of growth factors, chemokines and inflammatory mediators provide temporal and spatial control of ESC migration and invasiveness in the endometrium. Conversely, pelvic inflammation may be an important cue for endometrial cells in menstrual effluent to migrate and implant at distant sites, thus establishing a feedforward loop that leads to chronic pelvic endometriosis. If correct, this model suggests that molecules that target ESC invasiveness may be useful in halting disease progression. To be clinically useful, however, delivery systems that selectively target ectopic ESCs may be required to avoid adverse effects on normal uterine function.
Upon decidualization, ESCs exhibit a striking propensity to migrate towards non-autologous signals from embryos and trophoblast. While speculative, the most parsimonious explanation for this phenomenon may lie in maternal -fetal conflict. The premise of the conflict hypothesis is that the relationship between the mother and fetus is continuously shaped by natural selection (Haig, 2010) . Briefly, because of inborn differences in evolutionary interests, the embryonic (epi-)genome has evolved to extract as much as possible from the mother to ensure their propagation, whereas maternal genes will evolve to safeguard success not only of current but also future offspring. Taking into account the intrinsic genomic instability that characterises human preimplantation embryonic development, the maternal -fetal conflict hypothesis predicts that a strategy must have evolved to safeguard the mother against prolonged investment in invasive but developmentally abnormal embryos. In other words, reproductive success in human beings depends largely on the ability to reject unwanted concepti. Co-culture experiments indicate that this process of maternal rejection includes (i) insufficient encapsulation by decidualizing cells of abnormal embryos that have breached the luminal epithelium and (ii) selective silencing of key maternal implantation cytokines and growth factors. Impaired decidualization and falling progesterone levels in response to inadequate hCG then trigger menstruation-like shedding of the early conceptus. In RPL, failure to timely activate rejection mechanisms increases the likelihood of clinical recognition of unviable pregnancies. Further, impaired decidualization will inevitably compromise subsequent placental development in euploidic pregnancies. Conversely, it is conceivable that premature or excessive rejection underpins conception delay or recurrent implantation failure upon IVF treatment. Figure 2 Signalling pathways implicated in ESC migration and support of blastocyst implantation. Growth factors, including EGF, fibroblast growth factor-2, heparin-binding EGF-like growth factor and plateletderived growth factor-BB bind to receptor tyrosine kinases (RTKs), activate extracellular signal-regulated kinases (ERK)1/2 and phosphatidylinositol-3-kinase (PI3K)/Akt in ESCs and stimulate migration. Chemokines, such as C-C motif ligand (CCL)2 and endocannabinoids, bind to GPCRs and also feed into the ERK1/2 and PI3K pathways. PI3K further activates the Rho GTPase Rac1, which antagonizes RhoA. RhoA activity in ESCs is anti-migratory; it induces ROCK activity leading to increased levels of phosphorylated MLC (p-MLC) in a dual fashion: by phosphorylating MLC and by inhibiting MLC phosphatase (MLCP). As a result, stress fibre formation and focal adhesion increase, resulting in a suppression of migratory activity. Antagonism of this pathway by Rac1 relieves suppression. Enhanced ESC migration supports blastocyst implantation.
It is striking that several studies have demonstrated that the aberrant ESC motility associated with reproductive disorders, such as endometriosis, adenomyosis and pregnancy loss, is recapitulated in primary cultures or co-cultures (Ornek et al., 2008; Mehasseb et al., 2010; Weimar et al., 2012) . This cellular 'memory' suggests that ESCs are subjected to epigenetic programming in both normal and pathological conditions (Grimaldi et al., 2011 (Grimaldi et al., , 2012 . Further, there is evidence that this aberrant behaviour is mimicked by progenitor MSCs (Kao et al., 2011a) . This suggests that the requirement for continuous stem cell recruitment and maturation in order to renew and regenerate the endometrium in menstruating species may be at the basis of common reproductive disorders. Finally, the human endometrium is not only rich in MSCs but these cells are reportedly immuno-privileged compared with other types of stem cells. Recently, decidua-derived human MSCs have been shown to migrate and invade mammary tumours in a preclinical rat model of breast cancer (Vegh et al., 2012) . As a result, the growth of tumours was inhibited as was de novo tumour formation. Furthermore, the potential of clinical grade menstrual blood-derived endometrial MSCs to treat congestive heart failure is being tested in a phase II clinical trial (Phase II RECOVER-ERC Heart Failure Trial; http://medisteminc.com/2012/ medistem-and-ercell-initiate-phase-ii-recover-erc-heart-failure-trial/).
Conclusion
Studies on ESC motility and invasiveness in endometriosis represented a majority of publications identified in our search. However, our survey revealed that ESC migration is increasingly implicated in all aspects of endometrial functions, ranging from the control of embryo implantation and decidualization to tissue regeneration in response to menstruation and parturition. Harnessing the migratory capacity of ESCs and their Figure 3 Proposed roles of ESC migration in normal and disturbed reproductive function. A cross-sectioned uterus is displayed (top), which is divided into two parts: a uterus in the secretory phase during the window of implantation (left) and a uterus in the menstrual phase (right). On the left, a Day 5 embryo has arrived in the uterine cavity and is starting to implant. In normal fertile women a selective migratory response of decidualizing ESCs is responsible for embryo selection through active encapsulation of high-quality, but not chromosomally abnormal, embryos. The inhibition of migration in response to compromised embryos does not occur in women with recurrent miscarriage, resulting in non-viable pregnancies. On the right, ESC migration in menstrual repair promotes regeneration of the endometrial compartment. The ability of ectopic ESCs to migrate, survive in the pelvic cavity and invade the peritoneal mesothelium leads to formation of endometriotic lesions.
Endometrial stromal cell migration progenitor cells is a challenging but worthwhile endeavour as it may not only lead to radically novel treatments for reproductive disorders but also to new opportunities for regenerative medicine.
